DukesMNG. Meyler's side effects of drugs. 11th ed. Amsterdam: Elsevier, 1988: 405–7.
2.
BezahlerGH. Fatal methyldopa-associated granulomatous hepatitis and myocarditis. Am J Med Sci1982; 283: 41–5.
3.
RodmanJSDeutschDJGutmanSI. Methyldopa hepatitis. A report of six cases and review of the literature. Am J Med1976; 60: 941–8.
4.
ToghillPJSmithPGBentonPBrownRCMatthewsHL. Methyldopa liver damage (letter). Br Med J1974; 3: 545.
5.
BeaugrandNGavillonCFerrerJP. Présence d'un titre élevé d'anticorps antireticulum endoplasmique chez un malade atteint d'une hépatite chronique active due à l'alphametildopa (letter). Gastroenterol Clin Biol1980; 4: 219.
6.
KarchFELasagnaL. Toward the operational identification of adverse drug reactions. Clin Pharmacol Ther1977; 21: 247–54.
